About Metformin Hydrochloride Prolonged Release Glimepiride Tablets IP
Metformin Hydrochloride Prolonged Release Glimepiride Tablets IP, presented by Unika, are a cost-effective and highly recommended choice for the management of Type 2 diabetes in adults. Each white, first-class tablet combines the elite performance of metformin (biguanide) and glimepiride (sulfonylurea), offering best price value without compromising efficacy. Formulated as a prolonged-release oral antidiabetic, these IP-certified tablets provide reliable and sustained blood glucose regulation. The pharmaceutical-grade purity and first-rate manufacturing assure safety and quality. Available in convenient 10x15 tablet blister strips, they are suitable for daily use as prescribed by your physician.
Targeted Application for Comprehensive Diabetes Care
Metformin Hydrochloride Prolonged Release Glimepiride Tablets IP are designed for oral administration and act systemically to lower blood glucose levels in adults with Type 2 diabetes. The surface of application is the digestive tract, with absorption occurring primarily in the intestines. These elite tablets are highly recommended for chronic, long-term management of diabetes under medical supervision, supporting controlled and steady blood sugar levels with every dose.
Packaging, Delivery, and Supply Information
Our first-class tablets are shipped promptly in secure blister strips, with each box containing 10x15 tablets. Dispatched directly from India, they are packaged to maintain pharmaceutical-grade quality and extended shelf life. We ensure a rapid supply ability to meet demand, and the asking price is transparent and competitive for bulk traders and healthcare suppliers. Rest assured, your order will be managed efficiently from dispatch to delivery for maximum safety and satisfaction.
FAQ's of Metformin Hydrochloride Prolonged Release Glimepiride Tablets IP:
Q: How should Metformin Hydrochloride Prolonged Release Glimepiride Tablets IP be used?
A: These tablets must be taken orally as prescribed by your physician, following the specific dosage guidelines for adults with Type 2 diabetes. Do not alter the dose without consulting your doctor.
Q: What are the main benefits of this prolonged-release formulation?
A: The prolonged-release property ensures a steady release of medication, offering stable blood glucose control and potentially reducing side effects compared to immediate-release forms.
Q: When can I expect my order to be dispatched after purchase?
A: Orders are typically processed and dispatched promptly upon confirmation, with shipping details provided for your convenience. Delivery timelines may vary based on location and order volume.
Q: Where should I store these tablets?
A: Store the tablets in a cool, dry place as per the storage instructions on the packaging, away from direct sunlight and moisture, to maintain efficacy throughout the shelf life.
Q: What makes these tablets suitable for adults with Type 2 diabetes?
A: Their combination of metformin and glimepiride, supported by regulatory IP standards and pharmaceutical-grade quality, ensures effective and safe treatment for adults managing Type 2 diabetes.
Q: How do I know if Metformin Hydrochloride Prolonged Release Glimepiride Tablets IP are right for me?
A: Consult your healthcare provider for an assessment. These tablets are prescription-only (Rx) and intended for adults diagnosed with Type 2 diabetes who require a combination therapy.